← Back to Search

Enhanced Referral/Linkage to Care for Psychosis (JJ-Psychosis Trial)

N/A
Waitlist Available
Led By Anthony Spirito, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month follow-up
Awards & highlights

JJ-Psychosis Trial Summary

This trial will study if giving mental health referrals to young people in the Juvenile Justice System will help them get treatment.

Eligible Conditions
  • Psychosis

JJ-Psychosis Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Treatment linkage/retention in CSC services
Secondary outcome measures
Psychosis-spectrum symptoms and diagnoses

JJ-Psychosis Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced Referral/Linkage to CareExperimental Treatment1 Intervention
The experimental condition will include a psychoeducational and motivational enhancement protocol completed at the JJS intake appointment, paired with a "warm hand-off" referral to the CSC for evaluation and initiation of mental health services.
Group II: Standard Care/Baseline ControlActive Control1 Intervention
Standard care is the typical process of referral to mental health services for Juvenile Justice (JJ) youth who screen positive for mental heath concerns at intake. For this study, baseline control participants will be referred to the Coordinated Specialty Care (CSC) clinic due to their endorsement of psychosis-spectrum symptoms.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Enhanced Referral/Linkage to Care
2018
N/A
~160

Find a Location

Who is running the clinical trial?

Brown UniversityLead Sponsor
456 Previous Clinical Trials
558,194 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,783 Previous Clinical Trials
2,688,967 Total Patients Enrolled
47 Trials studying Psychosis
10,719 Patients Enrolled for Psychosis
Anthony Spirito, PhDPrincipal Investigator - Brown University
Brown University
11 Previous Clinical Trials
827 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age restriction for participants in this experiment above or below 25?

"This trial requires participants to be in the 12-17 age range. The research team has identified 112 studies for minors and 257 reports related to elderly patients."

Answered by AI

Who qualifies to join this medical experiment?

"The current clinical trial seeks out 270 adolescents between the ages of 12 and 17 who are suffering from a psychotic disorder. For inclusion into this study, participants must meet additional requirements: be currently in contact with the Juvenile Justice System, have their legal guardian grant consent for participation, and provide assent to take part in the experiment."

Answered by AI

Is recruitment still ongoing for this experiment?

"Affirmative. Clinicaltrials.gov details that this clinical trial, initially released on September 1st 2018 is presently seeking participants. 270 individuals are required to be enrolled between two medical centres."

Answered by AI

How many participants are currently being recruited for this trial?

"Affirmative. Clinicaltrials.gov indicates that this research endeavor, which was originally posted on September 1st 2018, is currently recruiting for 270 participants from two distinct clinical sites."

Answered by AI
~24 spots leftby Apr 2025